Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
GlobeNewswire, Inc.
Espoo, Finland, 11 November 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, today announces that the Horizon Europe-funded research Project...
Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design
GlobeNewswire, Inc.
Phase 2 study will assess HER-096’s efficacy in approximately 100 participants, using a smartphone-based motor assessment as the primary efficacy endpoint, including nine months of placebo-controlled treatment followed by six months of HER-096...
UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
GlobeNewswire, Inc.
FREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX: NHLTY, NGHLF) today announced the launch of the UK Biobank vanguard study...
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
GlobeNewswire, Inc.
FREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX: NHLTY, NGHLF) today announced the launch of the UK Biobank vanguard study...
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off
GlobeNewswire, Inc.
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off Rebuilt platform combines AI-powered 12-lead ECG analysis, editable findings, and clinician sign-off in one browser tab. HELSINKI, Finland,...
Memorandum of Understanding Between The Government of the United States of America and the Government of Finland Regarding the Technology Prosperity Deal
The White House
The Government of the United States of America and the Government of Finland (hereinafter referred to as the “Participants”), Expressing mutual interest in science and technology capabilities and standards to usher in the next Golden Age of...
EU EASTERN BORDERS: Major drop in irregular crossings so far in 2026 ― Finnish PM’s party proposes tighter asylum rules ― Finnish government planning to spend €100 million on anti-personnel mines ― Latvian government planning to further empower border …
European Council on Refugees and Exiles (ECRE)
There has been a major decrease in the number of recorded irregular border crossings on the Eastern Borders migration route in the first nine months of 2026. The largest party in the Finnish government coalition has proposed to tighten the...
AKC Canine Health Foundation Announces Semifinalists for 2026 Canine Health Discovery of the Year Award
GlobeNewswire, Inc.
RALEIGH, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- The AKC Canine Health Foundation (CHF) today named eight semifinalists for the 2026 Canine Health Discovery of the Year Award, which honors the year’s most important advancements in canine health....
Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)
GlobeNewswire, Inc.
Phase 2 trial to evaluate SUN-627, a potent, highly-selective, brain-penetrant, oral allosteric TYK2 inhibitor, in people with progressive forms of MS Novel brain-penetrant TYK2 inhibitor offers differentiated approach for the treatment of...
Elemental Wellness Club Brings a New Social Wellness Experience to Northeast Ohio with a Phone-Free Environment
EIN Presswire
Westlake club combines sauna, cold plunge, guided contrast therapy, wellness technology, and community under one roof.
Ten Reputable Indoor Sauna Room Companies in 2026: Advancing Wellness Design, Energy Efficiency, and Safety Standards
EIN Presswire
An overview of established manufacturers and the product design, energy-efficiency, and safety practices influencing the indoor sauna room sector.
3 E Network Issues Strategic Update on Finnish AI Compute Center Following 9 MVA Grid Connection Agreement
GlobeNewswire, Inc.
HONG KONG, Oct. 20, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider committed to becoming a...
3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland
GlobeNewswire, Inc.
HONG KONG, Oct. 19, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider committed to becoming a...
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
GlobeNewswire, Inc.
October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this month Project aims to help cardiac patients avoid...
Top 10 Customized Elevator Dimensions Solution Providers in 2026
EIN Presswire
A professional overview of specification planning, cabin material selection, and project-fit considerations for elevator procurement.
Nouryon cleared by regulators to supply a plant-based, water-soluble pharmaceutical ingredient in China's expanding drug manufacturing market
GlobeNewswire, Inc.
Global specialty chemicals leader Nouryon today announced the company has received clearance to supply a key pharmaceutical ingredient for medicines made and sold in China, one of the world’s largest drug manufacturing markets.
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing Milestone marks Orion Pharma’s entry...
Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders
GlobeNewswire, Inc.
Differentiated approach directly and selectively enhances TrkB activity, a central regulator of neuroplasticity New funds will advance lead programme KTX-0141 through IND/CTA-enabling studies and Phase 1/1b clinical development targeting major...
AMSA and ŌURA Collaborate to Make Innovation Fest 2026 the Best Student-Led Health Tech Event Yet
EIN Presswire
MCCLEAN, VA, UNITED STATES, September 24, 2026 /EINPresswire.com/ -- The American Medical Student Association (AMSA) and ŌURA, a leading health intelligence platform and maker of the world’s smallest smart ring, today announced that Oura will...
ŌURA Joins Workday Wellness, Giving Employers a New Way to Fund Oura Ring as a Flexible Benefit
GlobeNewswire, Inc.
SAN FRANCISCO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ŌURA, a leading health intelligence platform and maker of the world's smallest smart ring, today announced it has joined Workday Wellness, an AI-powered platform that gives employers a real-time...
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.